In a recent review published in the Open Forum Infectious Diseases journal, researchers reported on the evolution of multidrug-resistant tuberculosis (MDR-TB) therapy. Study: At long last: short, ...

Despite newer TB drugs, delayed diagnosis, atypical symptoms and drug resistance continue to complicate treatment ...

Please provide your email address to receive an email when new articles are posted on . Findings from a recent study support substituting bedaquiline for second-line injectables in treatment for ...

Johns Hopkins researchers have developed a computer simulation that helps predict under which circumstances a new short-course treatment regimen for drug-resistant tuberculosis could substantially ...

Please provide your email address to receive an email when new articles are posted on . Tuberculosis killed 1.6 million people in 2017 — more than 4,000 each day. Among its deadly attributes, TB is ...

Sydney researchers have found that Levofloxacin substantially reduces risk of drug-resistant tuberculosis. This discovery offers new hope against a disease that infects more than 400,000 people ...

patients Punakha four patient locked contentadvisable Karma fulfilling less locked contentfour Choden patient hospitals.<br><br>National locked contentfulfilling Bhutan less it locked contentpatient ...

There were an estimated 490,000 new cases of drug-resistant TB in 2016. Tuberculosis, a lung disease most often transmitted by breathing infected particles in the air, is the ninth leading cause of ...

Tuberculosis (TB) may last for several months, with treatment. The length of time it takes to cure the condition can vary. It may depend on whether the TB is latent or active. Tuberculosis (TB) is a ...